A step forward in regenerating and repairing damaged nerve cells
A team of IRCM researchers, led by Dr. Frédéric Charron, recently uncovered a nerve cell’s internal clock, used during embryonic development. +++ »
A step forward in regenerating and repairing damaged nerve cells
A team of IRCM researchers, led by Dr. Frédéric Charron, recently uncovered a nerve cell’s internal clock, used during embryonic development. +++ »
A study from the Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic neuropathy in a 12-week placebo controlled clinical study. +++ »
A scientist at the University of British Columbia and Vancouver Coastal Health has identified the molecule that controls a scissor-like protein responsible for the production of plaques – the telltale sign of Alzheimer’s disease (AD).
Researchers at the Douglas Mental Health University Institute, have discovered a new genetic process that could one day provide a novel target for the treatment of neurodevelopmental disorders, such as intellectual disability and autism.
TORONTO – Researchers at The Hospital for Sick Children (SickKids) have found that metformin, a drug commonly used to treat Type II diabetes, can help trigger the pathway used to instruct stem cells in the brain to become neural (nerve) cells. +++ »
Researchers from McGill University and the University of Montreal have identified a crucial link between protein synthesis and autism spectrum disorders (ASD), which can bolster new therapeutic avenues. Regulation of protein synthesis, also termed mRNA translation, is the process by which cells manufacture proteins. +++ »